Jove
Visualize
Contact Us

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sharing an Example of Neurodiversity Affirmative Hiring.

Autism in adulthood·2026
Same author

A novel commensal <i>Neisseria</i> species harboring the gonococcal diagnostic marker DR-9 causes false-positive Roche cobas NAAT results.

Journal of clinical microbiology·2025
Same author

Efficient nonviral integration of large transgenes into human T cells using Cas9-CLIPT.

Molecular therapy. Methods & clinical development·2025
Same author

Noninvasive Monitoring of Humoral Immune Responses in Men With Acute Chlamydia trachomatis Urethral Infection Using First-Catch Urine.

The Journal of infectious diseases·2025
Same author

Audiology evaluation following intra-arterial carboplatin for retinoblastoma.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2024
Same author

Ultrafast mode-locked laser in nanophotonic lithium niobate.

Science (New York, N.Y.)·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 25, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

14.1K

Improving DNA vaccine performance through vector design.

James A Williams1

  • 1Nature Technology Corporation/ Suite 103, 4701 Innovation Drive, Lincoln, NE 68521, USA. jim@natx.com.

Current Gene Therapy
|August 22, 2014
PubMed
Summary
This summary is machine-generated.

Innovations in DNA vaccine technology, including improved vectors and synthetic antigen design, enhance gene transfer and immune responses for human and animal diseases. These advancements aim for safer, more effective, and cost-efficient vaccine production.

More Related Videos

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.2K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.0K

Related Experiment Videos

Last Updated: Apr 25, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

14.1K
Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants
09:20

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus AAV Capsid Variants

Published on: October 18, 2022

5.2K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

8.0K

Area of Science:

  • Vaccinology
  • Molecular Biology
  • Biotechnology

Background:

  • DNA vaccines represent a next-generation platform for treating human and animal diseases.
  • Delivery devices like electroporation enhance gene transfer, leading to improved antigen expression and immunity.

Purpose of the Study:

  • To review recent innovations in DNA vaccine vector and transgene design.
  • To highlight advancements improving DNA vaccine performance, manufacturing, and safety.

Main Methods:

  • Review of recent vector and transgene design innovations.
  • Presentation of a flowchart for designing synthetic antigen transgenes using targeting, codon-optimization, and bioinformatics.
  • Discussion of manufacturing technologies for plasmid production.

Main Results:

  • New vectors enhance antigen expression and plasmid manufacturing yield and quality.
  • Innovations eliminate antibiotic selection, addressing potential safety concerns.
  • Synthetic transgene design integrates targeting, codon-optimization, and bioinformatics.

Conclusions:

  • Improved vectors, antibiotic-free plasmid production, and cost-effective manufacturing are crucial for DNA vaccine development.
  • These advancements are vital for ensuring the safety, efficacy, and economic viability of DNA vaccines for various indications.
  • Further development is critical for infectious diseases, cancer, autoimmunity, immunotolerance, and allergy treatments.